Akebia Therapeutics Announces September 2021 Investor Conference Schedule

Akebia Therapeutics, Inc. (Nasdaq: AKBA) announced a series of investor conference participations.

Rhea-AI Summary

Akebia Therapeutics, Inc. (Nasdaq: AKBA) announced a series of investor conference participations. CEO John P. Butler and CFO David A. Spellman will partake in three significant conferences this September, including the Morgan Stanley Global Healthcare Conference on September 9, H.C. Wainwright Global Investment Conference on September 13, and Cantor Fitzgerald Global Healthcare Conference on September 27. These events aim to update investors about Akebia's progress in developing therapeutics for kidney disease. Live webcasts of these events will be available on the company's investor relations website.

Positive

• Participation in multiple investor conferences may enhance investor engagement and visibility.
• Live webcasts of presentations will provide broader access to potential investors.

Negative

• None.

Argus Session date unavailable

+3.74% session move Open Argus

Details

News Market Reaction – AKBA

The recorded move for AKBA in the trading session of this news was +3.74%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., Sept. 1, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer, and David A. Spellman, Chief Financial Officer, will participate in the following schedule of investor conferences:

•   Morgan Stanley 19^th Annual Global Healthcare Conference
  Virtual fireside chat at 2:45 p.m. ET on September 9
  
  
• H.C. Wainwright 23^rd Annual Global Investment Conference
  On-demand presentation available at 7:00 a.m. ET on September 13
  
  
• Cantor Fitzgerald Virtual Global Healthcare Conference 2021
  Virtual presentation at 2:00 p.m. ET on September 27

Where applicable, live webcasts of Akebia's fireside chats and presentations will be made available on the Investors section of the Company's website at https://ir.akebia.com .

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Kristen K. Sheppard, Esq.
ir@akebia.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-announces-september-2021-investor-conference-schedule-301366758.html

SOURCE Akebia Therapeutics

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Akebia Therapeutics' conference schedule for September 2021?

Akebia Therapeutics will participate in the Morgan Stanley Global Healthcare Conference on September 9, the H.C. Wainwright Global Investment Conference on September 13, and the Cantor Fitzgerald Global Healthcare Conference on September 27.

Who will represent Akebia Therapeutics at the upcoming investor conferences?

CEO John P. Butler and CFO David A. Spellman will represent Akebia Therapeutics at the conferences.

How can investors access Akebia Therapeutics' conference presentations?

Investors can access live webcasts of Akebia's presentations on the Investors section of their website.